Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049970003> ?p ?o ?g. }
- W2049970003 endingPage "1408" @default.
- W2049970003 startingPage "1387" @default.
- W2049970003 abstract "Introduction: Antimuscarinics (AMs) are the mainstay of pharmacological treatment of overactive bladder (OAB), a symptom complex defined by the presence of urinary urgency, usually associated with frequency and nocturia, with or without urgency urinary incontinence. The AMs used to treat OAB differ in their pharmacological profiles, which may affect their potential for causing adverse effects (AEs). Areas covered: The present article aims to review the literature about pharmacokinetics (PK) of the different AMs used in the treatment of OAB. Furthermore, the AEs related to the use of these drugs and their incidence are presented. This systematic review is based on material searched and obtained via Medline, Pubmed and EMBASE up to March 2012 using the search terms “adverse events, pharmacokinetics, tolerability” in combination with “darifenacin, fesoterodine, imidafenacin, oxybutynin, propiverine, solifenacin, tolterodine, and trospium.” Expert opinion: Antimuscarinics are the first-line pharmacological treatment for OAB. Despite the development of new molecules that improve their efficacy/safety profile, there are some drugs that are pharmacokinetically more appropriate to be prescribed in specific populations such as patients with neurological disease or the elderly. Moreover, research should be encouraged in evaluating antimuscarinics in conjunction with other drugs such as estrogens or beta-agonists. The identification of prognostic criteria for pharmacological therapy would be helpful." @default.
- W2049970003 created "2016-06-24" @default.
- W2049970003 creator A5011886416 @default.
- W2049970003 creator A5021574752 @default.
- W2049970003 creator A5033337879 @default.
- W2049970003 creator A5039654830 @default.
- W2049970003 creator A5063590653 @default.
- W2049970003 creator A5075844307 @default.
- W2049970003 creator A5084134520 @default.
- W2049970003 creator A5085905929 @default.
- W2049970003 date "2012-08-08" @default.
- W2049970003 modified "2023-10-02" @default.
- W2049970003 title "Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females" @default.
- W2049970003 cites W1479893415 @default.
- W2049970003 cites W1489359480 @default.
- W2049970003 cites W1496249181 @default.
- W2049970003 cites W1522700698 @default.
- W2049970003 cites W1534712508 @default.
- W2049970003 cites W1557824654 @default.
- W2049970003 cites W1560600210 @default.
- W2049970003 cites W1561545570 @default.
- W2049970003 cites W1573354163 @default.
- W2049970003 cites W1581463056 @default.
- W2049970003 cites W1585489386 @default.
- W2049970003 cites W1597433473 @default.
- W2049970003 cites W1720940903 @default.
- W2049970003 cites W1834240270 @default.
- W2049970003 cites W1898032589 @default.
- W2049970003 cites W1964307756 @default.
- W2049970003 cites W1967347194 @default.
- W2049970003 cites W1973321971 @default.
- W2049970003 cites W1974084711 @default.
- W2049970003 cites W1982005672 @default.
- W2049970003 cites W1986153368 @default.
- W2049970003 cites W1986547814 @default.
- W2049970003 cites W1986753920 @default.
- W2049970003 cites W1987641034 @default.
- W2049970003 cites W1988352349 @default.
- W2049970003 cites W1989372559 @default.
- W2049970003 cites W1989637542 @default.
- W2049970003 cites W1991658964 @default.
- W2049970003 cites W1993213910 @default.
- W2049970003 cites W1994653403 @default.
- W2049970003 cites W2001275235 @default.
- W2049970003 cites W2005286581 @default.
- W2049970003 cites W2006773204 @default.
- W2049970003 cites W2007048466 @default.
- W2049970003 cites W2009222272 @default.
- W2049970003 cites W2009822389 @default.
- W2049970003 cites W2009999455 @default.
- W2049970003 cites W2010258053 @default.
- W2049970003 cites W2012035882 @default.
- W2049970003 cites W2012897345 @default.
- W2049970003 cites W2013618220 @default.
- W2049970003 cites W2013625380 @default.
- W2049970003 cites W2013761368 @default.
- W2049970003 cites W2013908993 @default.
- W2049970003 cites W2016695126 @default.
- W2049970003 cites W2017922615 @default.
- W2049970003 cites W2019119348 @default.
- W2049970003 cites W2020336822 @default.
- W2049970003 cites W2021632936 @default.
- W2049970003 cites W2023368818 @default.
- W2049970003 cites W2024699082 @default.
- W2049970003 cites W2025864351 @default.
- W2049970003 cites W2026000498 @default.
- W2049970003 cites W2027905639 @default.
- W2049970003 cites W2031727858 @default.
- W2049970003 cites W2032650666 @default.
- W2049970003 cites W2033390639 @default.
- W2049970003 cites W2033781666 @default.
- W2049970003 cites W2034740672 @default.
- W2049970003 cites W2034782018 @default.
- W2049970003 cites W2035122195 @default.
- W2049970003 cites W2035527398 @default.
- W2049970003 cites W2036984404 @default.
- W2049970003 cites W2037706235 @default.
- W2049970003 cites W2039478464 @default.
- W2049970003 cites W2040008446 @default.
- W2049970003 cites W2042579742 @default.
- W2049970003 cites W2044988410 @default.
- W2049970003 cites W2046154712 @default.
- W2049970003 cites W2047009245 @default.
- W2049970003 cites W2049089514 @default.
- W2049970003 cites W2051443038 @default.
- W2049970003 cites W2052230544 @default.
- W2049970003 cites W2054263301 @default.
- W2049970003 cites W2054666668 @default.
- W2049970003 cites W2056759810 @default.
- W2049970003 cites W2057111125 @default.
- W2049970003 cites W2057928770 @default.
- W2049970003 cites W2058955332 @default.
- W2049970003 cites W2059240022 @default.
- W2049970003 cites W2060110594 @default.
- W2049970003 cites W2062622155 @default.
- W2049970003 cites W2064365016 @default.
- W2049970003 cites W2064430566 @default.
- W2049970003 cites W2066766678 @default.